Anna-Sophie Moldenhauer

1.9k total citations · 2 hit papers
14 papers, 1.0k citations indexed

About

Anna-Sophie Moldenhauer is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Anna-Sophie Moldenhauer has authored 14 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 7 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in Anna-Sophie Moldenhauer's work include SARS-CoV-2 and COVID-19 Research (7 papers), interferon and immune responses (4 papers) and Influenza Virus Research Studies (4 papers). Anna-Sophie Moldenhauer is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), interferon and immune responses (4 papers) and Influenza Virus Research Studies (4 papers). Anna-Sophie Moldenhauer collaborates with scholars based in Germany, Australia and Saudi Arabia. Anna-Sophie Moldenhauer's co-authors include Stefan Pöhlmann, Markus Hoffmann, Inga Nehlmeier, Luise Graichen, Georg M. N. Behrens, Hans‐Martin Jäck, Amy Kempf, Sebastian Schulz, Nadine Krüger and Martin Sebastian Winkler and has published in prestigious journals such as Cell, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Anna-Sophie Moldenhauer

13 papers receiving 1.0k citations

Hit Papers

The Omicron variant is highly resistant against antibody-... 2021 2026 2022 2024 2021 2024 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic
    2021 557 citations Markus Hoffmann, Nadine Krüger et al. Cell profile →
  2. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency
    2024 49 citations Lu Zhang, Amy Kempf et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna-Sophie Moldenhauer Germany 12 873 221 140 125 112 14 1.0k
Prerna Arora Germany 10 879 1.0× 208 0.9× 92 0.7× 84 0.7× 127 1.1× 18 961
Cheila Rocha Germany 13 725 0.8× 221 1.0× 114 0.8× 89 0.7× 77 0.7× 27 943
Prudence Kgagudi South Africa 7 685 0.8× 185 0.8× 69 0.5× 92 0.7× 108 1.0× 10 797
Karin van den Berg South Africa 10 704 0.8× 171 0.8× 71 0.5× 98 0.8× 106 0.9× 45 983
Alexander S. Hahn Germany 8 619 0.7× 181 0.8× 100 0.7× 106 0.8× 91 0.8× 18 762
Janin Nouhin Cambodia 15 876 1.0× 227 1.0× 93 0.7× 172 1.4× 55 0.5× 32 1.1k
Veronica Ueckermann South Africa 8 706 0.8× 226 1.0× 72 0.5× 60 0.5× 108 1.0× 26 824
Martin Müller Germany 8 585 0.7× 174 0.8× 120 0.9× 137 1.1× 98 0.9× 12 764
Liyuan Liu China 12 1.1k 1.2× 379 1.7× 263 1.9× 126 1.0× 141 1.3× 23 1.5k
Kefang Liu China 17 811 0.9× 280 1.3× 228 1.6× 113 0.9× 194 1.7× 43 1.1k

Countries citing papers authored by Anna-Sophie Moldenhauer

Since Specialization
Citations

This map shows the geographic impact of Anna-Sophie Moldenhauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna-Sophie Moldenhauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna-Sophie Moldenhauer more than expected).

Fields of papers citing papers by Anna-Sophie Moldenhauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna-Sophie Moldenhauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna-Sophie Moldenhauer. The network helps show where Anna-Sophie Moldenhauer may publish in the future.

Co-authorship network of co-authors of Anna-Sophie Moldenhauer

This figure shows the co-authorship network connecting the top 25 collaborators of Anna-Sophie Moldenhauer. A scholar is included among the top collaborators of Anna-Sophie Moldenhauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna-Sophie Moldenhauer. Anna-Sophie Moldenhauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hoffmann, Markus, Hannah Kleine‐Weber, Luise Graichen, et al.. (2024). Acquisition of a multibasic cleavage site does not increase MERS-CoV entry into Calu-3 human lung cells. Journal of Virology. 98(11). e0130524–e0130524.
2.
Zhang, Lu, Anne Cossmann, Metodi V. Stankov, et al.. (2024). Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion. iScience. 27(6). 109904–109904. 11 indexed citations
3.
Zhang, Lu, Amy Kempf, Inga Nehlmeier, et al.. (2024). SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency. Cell. 187(3). 596–608.e17. 49 indexed citations breakdown →
4.
Arora, Prerna, Lu Zhang, Nadine Krüger, et al.. (2022). SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies. Cell Host & Microbe. 30(8). 1103–1111.e6. 29 indexed citations
5.
Hoffmann, Markus, Heike Hofmann-Winkler, Nadine Krüger, et al.. (2021). SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination. Cell Reports. 36(3). 109415–109415. 162 indexed citations
6.
Arora, Prerna, Anzhalika Sidarovich, Nadine Krüger, et al.. (2021). B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination. Cell Reports. 37(2). 109825–109825. 56 indexed citations
7.
Hoffmann, Markus, Nadine Krüger, Sebastian Schulz, et al.. (2021). The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic. Cell. 185(3). 447–456.e11. 557 indexed citations breakdown →
8.
Hoffmann, Markus, et al.. (2019). Analysis of Resistance of Ebola Virus Glycoprotein-Driven Entry Against MDL28170, An Inhibitor of Cysteine Cathepsins. Pathogens. 8(4). 192–192. 2 indexed citations
9.
Zmora, Paweł, Markus Hoffmann, Heike Kollmus, et al.. (2018). TMPRSS11A activates the influenza A virus hemagglutinin and the MERS coronavirus spike protein and is insensitive against blockade by HAI-1. Journal of Biological Chemistry. 293(36). 13863–13873. 39 indexed citations
10.
Hoffmann, Markus, Inga Nehlmeier, Verena Krähling, et al.. (2018). Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells. Journal of Virology. 93(3). 25 indexed citations
11.
Zmora, Paweł, Stephanie Bertram, Inga Nehlmeier, et al.. (2017). Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin. PLoS ONE. 12(5). e0176597–e0176597. 16 indexed citations
12.
Zmora, Paweł, Anna-Sophie Moldenhauer, Heike Hofmann-Winkler, & Stefan Pöhlmann. (2015). TMPRSS2 Isoform 1 Activates Respiratory Viruses and Is Expressed in Viral Target Cells. PLoS ONE. 10(9). e0138380–e0138380. 32 indexed citations
13.
Gnirß, Kerstin, Paweł Zmora, Paulina Błażejewska, et al.. (2015). Tetherin Sensitivity of Influenza A Viruses Is Strain Specific: Role of Hemagglutinin and Neuraminidase. Journal of Virology. 89(18). 9178–9188. 31 indexed citations
14.
Winkler, Michael, Stephanie Bertram, Kerstin Gnirß, et al.. (2012). Influenza A Virus Does Not Encode a Tetherin Antagonist with Vpu-Like Activity and Induces IFN-Dependent Tetherin Expression in Infected Cells. PLoS ONE. 7(8). e43337–e43337. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prerna Arora Breakdown of academic impact, for papers by Cheila Rocha Breakdown of academic impact, for papers by Prudence Kgagudi Breakdown of academic impact, for papers by Karin van den Berg Breakdown of academic impact, for papers by Alexander S. Hahn Breakdown of academic impact, for papers by Janin Nouhin Breakdown of academic impact, for papers by Veronica Ueckermann Breakdown of academic impact, for papers by Martin Müller Breakdown of academic impact, for papers by Liyuan Liu Breakdown of academic impact, for papers by Kefang Liu
Rankless by CCL
2026